Formulation and Delivery - Biomolecular - Formulation

(W0930-01-02) Formulation Development of Enterically Protected Spray Dried Dispersions of Adrulipase

(W0930-03-14) Macrophage-Specific Nanoparticle Delivery of MicroRNAs to Mitigate Ventilator-Induced Lung Injury during Acute Respiratory Distress Syndrome (ARDS)

(M0930-04-19) Investigational Vaccine Induces Immune Correlates of Protection and Resistance to Infection against Neisseria gonorrhoeae in Mice

(T0930-04-22) Evaluating Immunization Efficacy of Self-administrable Subunit Microparticulate COVID-19 Vaccine Delivered by Nasal, Buccal, and Dermal Routes

(W0930-04-22) Subunit Particulate Vaccine Delivered by Microneedles Elicits Th-1 Skewed Immune Responses Protecting against RSV

(W0930-12-70) Novel Sidekick in Vaccine Formulations: Microparticle Autoinducer-1

(M1030-01-02) Biomimetic SARS-CoV-2 Spike Protein Nanoparticles as Viral Inhibitors against COVID-19

(W1030-07-37) Production and Optimization of Nanosac as a Soft Nanocarrier for siRNA Delivery to Solid Tumors

(T1130-03-15) Development and In Vitro Characterization of STAT6 siRNA Loaded PEGylated Gelatin Nanocarriers as an Anti-Asthmatic Therapy

(W1130-04-19) A Novel Solid the Lipid Nanoparticles Formulation with Anti-inflammatory Properties for RNA Delivery

(W1230-01-01) Trafficking of Acetalated Dextran Microparticles after Subcutaneous Injection

(M1230-01-02) Ionizable Lipid Nanoparticles for Precise Intracellular Delivery of CpG DNA Adjuvant

(T1230-01-02) Stabilization of Recombinant DNA in a Polymer Based Film Matrix

(W1230-07-37) Understanding the Effects of Varying Mannitol Concentrations on Inhalable Protein Formulations

(T1230-07-37) Using Enzymes to Accelerate PS80 Degradation and Elucidate Mechanistic Impacts of PS80 Degradation on Biologics Drug Product Quality

(T1230-07-42) Characterizing Potency of Model AAVs Using Imaging Flow Cytometry

(M1230-12-67) Spray-Dried Inhaled Solid Dispersion of Amodiaquine for Respiratory Disorders

(T1230-12-67) Stabilize and Formulate Yeast-Based Immunobiologics by Lyophilization for Oral Delivery

(T1330-03-17) Formulating Adenosine for Localized Delivery

(T1330-04-19) Developability Assessment as an Early De-risking Tool for Biopharmaceuticals: Case Study with Fusion-Proteins

(M1330-04-21) Preparation and Characterization of Poorly Soluble Protein (MET 0226) Liposomal Nanoparticle by High Press Homogenizer

(M1330-07-37) Preparation of Polymeric Albumin Nanoparticles by a One-Step Spray Drying Process

(T1330-07-40) An Oral Lipid Nanocomplex Incorporating BRD4 PROTAC and Vemurafenib Overcomes BRAF Inhibitor Resistance in Malignant Melanoma In Vivo

(T1330-12-67) Fourier Transform Infrared Spectroscopy (FT-IR) of Lyophilized RNA

(T1430-07-37) NanoFabTx™: A Step-by-Step Quick Screening Platform for Liposomal Drug Delivery Systems

(T1530-04-19) Hydrophobic Ion Pair for the Oral Delivery of Leucine-Enkephalin

(T1530-07-37) Attenuating Neuroinflammation and Promoting Neurogenesis through Co-delivery of Curcumin and Brain Derived Neurotrophic Factor (BDNF) for the Management of Alzheimer’s disease

(M1530-07-37) Bioengineered Smart Microcapsules Containing Natural Killer Cells for the Treatment of Pediatric Cancers

(T1530-07-41) Comparison of Trehalose and Sucrose in Preserving and Stabilizing Lyophilized Therapeutic Proteins

(T1530-12-67) Remote Loading of Auto-Antigens in PLGA Nanoparticles for the Treatment of Autoimmune Diseases

(T1030-04-24) Intracellular Delivery of Plasmid DNA Using TPGS Formulated Lipid Nanoparticles

(M1130-12-72) Inulin-Based Dual-Function Polymer for Enhanced Delivery of Nucleic Acids to the Kidney

(M1230-07-42) Investigating Protein-Excipient Interactions of a Multivalent V_HH Therapeutic Protein using NMR Spectroscopy

(M1330-04-24) Dual Immunization Against COVID-19 and Influenza Using Fast-Dissolving Buccal Films

(M1330-12-72) Leveraging Developability Risk Assessment Insights to Identify Key Structural Liabilities and Inform Formulation Strategy for Novel Biologics Modalities